Kent J. Weinhold

Overview

Best Publications

• 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

  H Mitsuya;K J Weinhold;P A Furman;M H St Clair

  2712
  Citations

• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

  P A Furman;J A Fyfe;M H St Clair;K Weinhold

  1810
  Citations

• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

  Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  1035
  Citations

• Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

  Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  906
  Citations

• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  G J LaRosa;J P Davide;K Weinhold;J A Waterbury

  876
  Citations

• The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

  Nilu Goonetilleke;Michael K.P. Liu;Jesus F. Salazar-Gonzalez;Guido Ferrari

  810
  Citations

• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

  Thomas J. Palker;Michael E. Clark;Alphonse J. Langlois;Thomas J. Matthews

  701
  Citations

• T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

  Karolina Woroniecka;Pakawat Chongsathidkiet;Kristen Rhodin;Hanna Kemeny

  631
  Citations

• HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

  SD Putney;TJ Matthews;WG Robey;DL Lynn

  458
  Citations

• A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.

  Hamilton Jd;Hartigan Pm;Simberkoff Ms;Day Pl

  455
  Citations

• 3'-azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

  M H St Clair;C A Richards;T Spector;K J Weinhold

  391
  Citations

• Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

  H K Lyerly;T J Matthews;A J Langlois;D P Bolognesi

  315
  Citations

• Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion

  T J Matthews;K J Weinhold;H K Lyerly;A J Langlois

  304
  Citations

• Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

  Guido Ferrari;Will Humphrey;M. Juliana McElrath;Jean–Louis Excler

  299
  Citations

• Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

  Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  286
  Citations

• Standardization of cytokine flow cytometry assays

  Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

  281
  Citations

• HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.

  K J Weinhold;H K Lyerly;S D Stanley;A A Austin

  262
  Citations

• High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.

  Justin Pollara;Lydia Hart;Faraha Brewer;Joy Pickeral

  258
  Citations

• A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

  Thomas G. Evans;Michael C. Keefer;Kent J. Weinhold;Mark Wolff

  258
  Citations

• Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

  Robert B. Belshe;Geoffrey J. Gorse;Mark J. Mulligan;Thomas G. Evans

  247
  Citations

• Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

  Barton F. Haynes;Laura P. Hale;Kent J. Weinhold;Dhavalkumar D. Patel

  241
  Citations

• Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection

  S. Munir Alam;Richard M. Scearce;Robert J. Parks;Kelly Plonk

  199
  Citations

• Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

  Robert B. Belshe;Cladd Stevens;Geoffrey J. Gorse;Susan Buchbinder

  194
  Citations

• Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection

  Michael R. Betts;Barbara Exley;David A. Price;Anju Bansal

  177
  Citations

• QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

  Thomas G. Evans;M.Juliana McElrath;Tom Matthews;David Montefiori

  174
  Citations